P68400 (CSK21_HUMAN) Homo sapiens (Human)

Casein kinase II subunit alpha UniProtKBInterProSTRINGInteractive Modelling

391 aa; Sequence (Fasta) ; (Isoform 2); 62 identical sequences

Available Structures

232 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of Human Protein Kinase CK2 Holoenzyme Heteromer
P67870;
2-337
PO4;ANP;ZN;
Assess
Crystal Structure of the CK2 Tetrameric Holoenzyme Heteromer
P67870;
2-335
ZN;
Assess
Crystal Structure of full-length symmetric CK2 holoenzyme Heteromer
P67870;
2-333
ZN;
Assess
Crystal structure of a heterotetrameric CK2 holoenzyme complex carrying the Andante-mutation in CK2… Heteromer
P67870;
2-333
MG;ACP;GOL;ZN;
Assess
Crystal Structure of full-length symmetric CK2 holoenzyme with mutated alpha subunit (F121E) Heteromer
P67870;
2-333
ZN;
Assess
Crystal Structure of symmetric CK2 holoenzyme with mutated alpha subunit (F121E truncated at aa 336) Heteromer
P67870;
2-330
ZN;
Assess
The Crystal structure of CK2a bound to P1-C4 Heteromer
P67870;
3-329
BEZ;
Assess
Structure of an O-GlcNAc transferase point mutant, D554N in complex with peptide Heteromer
O15294;
339-352
UDP;SO4;NAG;
Assess
Crystal structure of human O-GlcNAc Transferase in complex with UDP and a glycopeptide Heteromer
O15294;
340-352
UDP;NAG;SO4;
Assess
Crystal structure of human O-GlcNAc Transferase with UDP-5SGlcNAc and a peptide substrate Heteromer
O15294;
340-352
12V;SO4;
Assess
A Neutral Diphosphate Mimic Crosslinks the Active Site of Human O-GlcNAc Transferase Heteromer
O15294;
340-352
UDP;FOR;SO4;
Assess
Crystal structure of human O-GlcNAc Transferase with UDP and a thioglycopeptide Heteromer
O15294;
340-352
UDP;SO4;0YT;
Assess
Structure of human O-GlcNAc transferase and its complex with a peptide substrate Heteromer
O15294;
340-352
UDP;SO4;
Assess
Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase Heteromer
O15294;
339-350
UDP;9C1;
Assess
O-GlcNAc Transferase in complex with covalent inhibitor Heteromer
O15294;
339-350
HQV;
Assess
Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase Heteromer
O15294;
339-350
UDP;9C1;9CD;
Assess
The crystal structure of CK2alpha in complex with compound 30homo-2-mer2-328
ACT;AQW;PO4;
Assess
The crystal structure of CK2alpha in complex with an analogue of compound 22homo-2-mer2-328
ACT;DMS;AT8;
Assess
The crystal structure of CK2alpha in complex with compound 25homo-2-mer2-328
ACT;AOW;PO4;PEG;
Assess
The crystal structure of CK2alpha in complex with compound 22homo-2-mer2-328
ACT;AWN;PO4;
Assess
The crystal structure of CK2alpha in complex with compound 21homo-2-mer2-328
ACT;AVK;
Assess
The crystal structure of CK2alpha in complex with compound 29homo-2-mer3-328
ACT;AQT;PO4;PEG;DMS;
Assess
The crystal structure of CK2alpha in complex with compound 24homo-2-mer3-328
ACT;AWK;PO4;PEG;
Assess
The crystal structure of CK2alpha in complex with compound 26homo-2-mer3-328
ACT;PO4;DMS;AQ8;
Assess
Crystal Structure of CK2alpha with compound 10 boundhomo-2-mer3-327
ACT;54S;DMS;PO4;
Assess
The crystal structure of CK2alpha in complex with compound 3homo-2-mer3-327
MG;ADP;A4Q;IHP;
Assess
The crystal structure of CK2alpha in complex with compound 6homo-2-mer4-327
ADP;MG;A4T;CL;PO4;
Assess
The crystal structure of CK2alpha in complex with compound 5homo-2-mer4-327
ADP;ACT;A4B;MG;IHP;CL;
Assess
Crystal structure of human CK2amonomer2-335
NIO; 19×EDO;
Assess
Crystal structure of CK2alphamonomer2-335
11×EDO;
Assess
Crystal structure of a mutant of human protein kinase CK2alpha with altered cosubstrate specificitymonomer2-335
CL;ANP;GOL;
Assess
Crystal structure of the CK2a1-go289 complexmonomer2-335
9NX;NA; 26×EDO;
Assess
Crystal structure of CK2a1 complexed with KY49monomer2-335
Y49;
Assess
Crystal structure of CK2a1 complexed with AG1112monomer2-335
8BH;
Assess
Crystal structure of CK2a1 V116I with hemateinmonomer2-335
EDO;E3U;
Assess
Crystal structure of the CK2alpha/compound10 complexmonomer2-335
LCT;
Assess
LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA) IN COMPLEX WITH THE I…monomer2-335
9YE;SO4;NA;
Assess
Crystal structure of human protein kinase CK2alpha (CSNK2A1 gene product) in complex with the ATP-c…monomer2-335
QWN;SO4;
Assess
High-salt structure of protein kinase CK2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (FLC…monomer2-335
3G5;CL;
Assess
Human CSNK2A1 bound to ERB-041monomer2-335
041;
Assess
Crystal structure of CK2a1 H115Y with hemateinmonomer2-335
E3U;
Assess
Structure of human CK2alpha in complex with the ATP-competitive inhibitor 3-(4,5,6,7-tetrabromo-1H-…monomer2-335
4B0;SO4;CL;
Assess
Inactive conformation of human protein kinase CK2 catalytic subunitmonomer2-335
GOL;SO4;CL;
Assess
High salt structure of human protein kinase CK2alpha in complex with 3-aminopropyl-4,5,6,7-tetrabro…monomer2-335
B0K;CL;
Assess
Crystal structure of CK2a1 H115Y/V116I with hemateinmonomer2-335
E3U;
Assess
Crystal structure of human CK2a with AMPPNPmonomer2-335
MG;ANP;EDO;
Assess
Crystal structure of human protein kinase CK2alpha (CSNK2A1 gene product) in complex with the ATP-c…monomer2-335
QWW;GOL;SO4;
Assess
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,6-DIBROMOBENZOTRIAZO…monomer2-334
NL2;CL;NA;PEG;
Assess
Crystal structure of the catalytic subunit of human protein kinase CK2 with 5,6-dichloro-1-beta-D-r…monomer2-334
RFZ; 14×CL;
Assess
HIGH-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA/CSKN2A1 GENE PRODUCT)…monomer3-335
CL;FXB;NA;
Assess
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,7-DIBROMOBENZOTRIAZO…monomer2-334
NKE;NA;CL;
Assess
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5-BROMOBENZOTRIAZOLEmonomer2-334
NKW;CL;NA;
Assess
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5,6-TRIBROMOBENZOTRI…monomer2-334
NKB;NA;CL;
Assess
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4-BROMOBENZOTRIAZOLEmonomer2-334
NKZ;CL;
Assess
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5-DIBROMOBENZOTRIAZO…monomer2-334
NKT;NA;
Assess
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5,6,7-TETRABROMOBENZ…monomer2-334
TBS;PEG;NA;CL;
Assess
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOTRIAZO…monomer2-334
7M0;FLC;FMT;
Assess
Crystal structure of human protein kinase CK2alpha (CSNK2A1 gene product) in complex with the ATP-c…monomer2-334
GOL;QXW;SO4;
Assess
H. SAPIENS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6,7,8-TETRABROM…monomer2-334
TBS;CL;PEG;
Assess
H. SAPIENS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOT…monomer2-334
7M0;CL;PEG;PG4;PGE;
Assess
Complex structure of human protein kinase CK2 catalytic subunit crystallized in the presence of a b…monomer2-334
CL;
Assess
H. SAPIENS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOT…monomer2-334
7M0;FLC;PEG;
Assess
Low-salt structure of protein kinase CK2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (FLC2…monomer2-334
3G5;
Assess
Structure of protein kinase ck2 catalytic subunit (csnk2a1 gene product) in complex with the bivale…monomer2-333
SO4;RXE;42J;
Assess
Structure of protein kinase CK2alpha mutant K198R associated with the Okur-Chung Neurodevelopmental…monomer2-333
EDO;SO4;CL;
Assess
LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA; CSNK2A1 gene product)…monomer2-333
EDO;CL;SO4;FXB;
Assess
HIGH-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA) IN COMPLEX WITH THE …monomer2-333
9YE;CL;
Assess
Crystal structure of human CK2 alpha in complex with Quinalizarin at pH 6.5monomer2-333
SO4;TXQ;EDO;
Assess
Crystal structure of human CK2 alpha complexed with Ellagic acidmonomer1-332
REF;
Assess
Tetragonal structure of human protein kinase CK2 catalytic subunit in complex with a heparin oligo …monomer2-333
IDS;GOL;SO4;
Assess
H. SAPIENS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOT…monomer3-334
7M0;
Assess
Crystal structure of CK2alpha with pyradine derivativemonomer1-332
ATK;
Assess
Crystal structure of human protein kinase CK2alpha (CSNK2A1 gene product) in complex with the 2-ami…monomer2-332
N4N;SO4;
Assess
CK2alpha in complex with NMR154monomer4-334
1KP;CL;
Assess
Crystal structure of CK2a1 H160A with hemateinmonomer2-332
E3U;
Assess
Crystal structure of CK2monomer2-332
SO4; 12×EDO;75E;
Assess
Crystal structure of CK2monomer2-332
SO4; 14×EDO;6XT;
Assess
Crystal structure of CK2 with compound 7hmonomer2-332
SO4; 14×EDO;5Y3;
Assess
Crystal structure of CK2alpha with pyradine derivertivemonomer2-332
CCK;
Assess
Structure of human protein kinase CK2 catalytic subunit in complex with a CK2beta-competitive cycli…monomer2-332
GOL;CL;
Assess
Complex structure of human protein kinase CK2 catalytic subunit with the inhibitor 4'-carboxy-6,8-c…monomer3-333
7FC;CL;
Assess
Crystal structure of CK2monomer2-332
SO4; 16×EDO;6XK;
Assess
Low salt structure of human protein kinase CK2alpha in complex with 3-aminopropyl-4,5,6,7-tetrabrom…monomer2-332
B0K;SO4;
Assess
Crystal structure of CK2 bound by compound 7monomer2-332
SO4;S92; 11×EDO;
Assess
CK2 alpha bound to Macrocyclemonomer3-333
SO4;PQ5;
Assess
Crystal structure of CK2 bound by compound 9monomer2-332
SO4; 12×EDO;S8W;
Assess
Crystal Structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunitmonomer2-332
CL;ANP;
Assess
Crystal structure of the protein kinase CK2 catalytic subunit in complex with pyrazolo-pyrimidine m…monomer2-332
SO4;EDO;8GQ;
Assess
Crystal structure of CK2 with compound 2monomer2-332
SO4;EDO;5Y2;
Assess
Tetragonal Complex Structure of Protein Kinase CK2 Catalytic Subunit with a Benzotriazole-Based Inh…monomer2-332
JRJ;SO4;CL;GOL;
Assess
Human CK2 catalytic domain in complex with CX-4945monomer2-332
3NG;SO4;
Assess
CK2 alpha bound to unclosed Macrocyclemonomer3-333
SO4;PQ8;
Assess
Crystal structure of the CK2alpha/compound3 complexmonomer2-332
LCD;
Assess
Structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit with the AT…monomer2-332
SO4;04G;GOL;CL;
Assess
Complex structure of human protein kinase CK2 catalytic subunit with the inhibitor 4'-carboxy-6,8-c…monomer2-331
7FC;GOL;CL;
Assess
Human CK2 catalytic domain in complex with a difurane derivative inhibitor (AMR)monomer2-331
14I;SO4;
Assess
Human CK2 catalytic domain in complex with a benzopyridoindole derivative inhibitormonomer2-331
18E;SO4;
Assess
Human CK2 catalytic domain in complex with a benzopyridoindole derivative inhibitormonomer2-331
19E;SO4;
Assess
CK2 alpha bound to chemical probe SGC-CK2-1monomer3-332
SO4;QBE;PEG;
Assess
Crystal structure of human CK2 alpha in complex with emodin at pH 6.5monomer2-331
EMO;EDO;7PE;SO4;
Assess
Crystal structure of the apo-form of human CK2 alpha at pH 6.5monomer2-331
SO4;EDO;
Assess
Crystal Structure of Human CK2-alpha in complex with a benzimidazole inhibitor (K164) at 1.25 A res…monomer2-330
SO4;EDO;EXX;PGE;PEG;DMS;
Assess
Monoclinic structure of human protein kinase CK2 catalytic subunit in complex with a heparin oligo …monomer2-330
IDS;GOL;NIO;
Assess
Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 1monomer2-330
SO4;EDO;JWQ;
Assess
Crystal structure of human Protein kinase CK2 catalytic subunit in complex with the ATP-competitive…monomer2-330
8QK;ACT;GOL;
Assess
Human CK2 catalytic domain in complex with a difurane derivative inhibitor (CPA)monomer3-331
01I;SO4;
Assess
Crystal structure of human Protein kinase CK2 catalytic subunit in complex with the ATP-competitive…monomer2-330
8QH;ACT;GOL;
Assess
Crystal structure of human Protein kinase CK2 catalytic subunit in complex with the ATP-competitive…monomer2-330
KC5;ACT;GOL;
Assess
Crystal structure of human CK2alpha in complex with the ATP-competitive inhibitor 4-[(E)-(fluoren-9…monomer2-330
GOL;E91;
Assess
Crystal structure of CK2a1 with hemateinmonomer2-330
E3U;
Assess
Complex structure of human protein kinase CK2 catalytic subunit with a thieno[2,3-d]pyrimidin inhib…monomer3-331
7EY;CL;GOL;
Assess
Structure of protein kinase CK2 catalytic subunit in complex with the CK2beta-competitive bisubstra…monomer2-330
9AB;
Assess
Casein Kinase II bound to Inhibitormonomer2-330
0Y4;CL;
Assess
Crystal structure of the CK2a/benzoic acid derivative complexmonomer2-330
HCK;
Assess
CK2 alpha bound to chemical probe SGC-CK2-1 derivativemonomer3-331
SO4;QB8;
Assess
Crystal structure of human CK2alpha complexed with a potent inhibitormonomer2-330
TID;
Assess
Complex structure of human protein kinase CK2 catalytic subunit with a thieno[2,3-d]pyrimidin inhib…monomer3-331
7EY;CL;
Assess
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with compound 2 (AA-CS…monomer3-331
SO4;QIA;
Assess
Crystal structure of P8C9 bound to CK2alphamonomer2-329
ADP;ACT;GOL;MG;PEG;SO4;NA;
Assess
Crystal structure of P7C8 bound to CK2alphamonomer2-329
ADP;GOL;MG;SO4;OUT;
Assess
Human protein kinase CK2 alpha in complex with ferulic aldehydemonomer3-330
SO4;CIY;EDO;
Assess
High pH-value crystal structure of emodin in complex with the catalytic subunit of protein kinase C…monomer3-330
CL;EMO;
Assess
Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 4monomer3-330
EDO;K0Z;SO4;
Assess
Human protein kinase CK2 alpha in complex with ferulic acidmonomer3-330
SO4;FER;EDO;
Assess
Human protein kinase CK2 alpha in complex with curcumin degradation productsmonomer3-330
SO4;EDO;FER;V55;GJK;CIY;
Assess
Crystal structure of the catalytic subunit of protein kinase CK2 (C-terminal deletion mutant 1-335)…monomer2-329
SO4;ANP;
Assess
Human protein kinase CK2 alpha in complex with boldinemonomer3-330
GHT;SO4;EDO;
Assess
Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 3monomer3-330
EDO;K0N;SO4;
Assess
Crystal structure of human CK2 alpha in complex with emodin at pH 8.5monomer3-330
EMO;SO4;
Assess
Crystal structure of CK2alpha with 2-hydroxy-5-methylbenzoic acid and (methyl 4-((3-(3-chloro-4-(ph…monomer2-329
551;54G;PO4;ACT;
Assess
Crystal structure of CK2alpha with (methyl 4-((3-(3-chloro-4-(phenyl)benzylamino)propyl)amino)-4-ox…monomer2-329
ACT;551;PO4;
Assess
Crystal structure of the apo-form of human CK2 alpha at pH 8.5monomer3-330
SO4;EDO;
Assess
Human protein kinase CK2 alpha in complex with feruloylmethanemonomer3-330
GJK;SO4;EDO;
Assess
Structure of human CK2 alpha kinase (catalytic subunit) with the inhibitor 108600.monomer3-330
SO4;GOL;ON6;
Assess
Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 7monomer3-330
K1B;EDO;SO4;
Assess
Human protein kinase CK2 alpha in complex with vanillinmonomer3-330
SO4;V55;
Assess
Human CK2 catalytic domain in complex with a pyridocarbazole derivative inhibitormonomer3-330
1EL;
Assess
The crystal structure of CK2alpha in complex with compound 7monomer2-329
ACT;ADP;MG;A9K;PO4;
Assess
Low pH-value crystal structure of emodin in complex with the catalytic subunit of protein kinase CK2monomer3-330
CL;EMO;
Assess
Human protein kinase CK2 alpha in complex with coumestrolmonomer3-330
CUE;SO4;
Assess
The crystal structure of CK2alpha in complex with compound 20monomer2-329
ACT;AW5;AVZ;
Assess
Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 14monomer3-330
JYZ;SO4;
Assess
Crystal structure of CK2alpha with ZT0627 boundmonomer2-329
HBD;ACT;
Assess
Monoclinic Complex Structure of Protein Kinase CK2 Catalytic Subunit with a Benzotriazole-Based Inh…monomer2-329
JRJ;SO4;GOL;
Assess
X-ray structure of protein kinase ck2 alpha subunit in D2Omonomer3-329
SO4;
Assess
Structure of Compound 17 bound to CK2alphamonomer3-329
ATP;ACT;LW3;PO4;
Assess
Crystal structure of P8C9 bound to CK2alphamonomer3-329
MG;ADP;GOL;NA;
Assess
X-ray structure of protein kinase ck2 alpha subunit H148A mutantmonomer3-329
SO4;
Assess
Human CK2 catalytic domain in complex with AMPPNmonomer2-328
GOL;SO4;MG;ANP;
Assess
Compound 9 Bound to CK2alphamonomer3-329
ADP;KEC;ACT;
Assess
The crystal structure of CK2alpha in complex with compound 9monomer3-329
ACT;AWE;TFA;
Assess
Crystal Structure of CK2alphamonomer3-329
ATP;ACT;
Assess
Crystal Structure of CK2alpha with Compound 6 boundmonomer3-329
ACT;GAB;
Assess
The crystal structure of CK2alpha in complex with compound 33monomer3-329
ACT;AUH;
Assess
The crystal structure of CK2alpha in complex with CAM4712 and compound 37monomer3-329
ACT;AUW;54G;
Assess
Structure of Compound 6 Bound to CK2alphamonomer3-329
ACT;ATP;KD6;
Assess
The Crystal structure of RO4613269 bound to CK2alphamonomer3-329
QY2;
Assess
Crystal structure of compound 7 bound to CK2alphamonomer3-329
KC0;ADP;
Assess
The Crystal structure of CK2a bound to P2-C4monomer3-329
GOL;BEZ;ACT;
Assess
The crystal structure of CK2alpha in complex with compound 1monomer3-329
ACT;TFA;AUT;
Assess
The Structure of CK2alpha with CCh503 boundmonomer3-329
503;ATP;
Assess
The crystal structure of CK2alpha in complex with CAM4712monomer3-329
ACT;TFA;AUW;
Assess
Crystal Structure of CK2alpha with Compound 5 boundmonomer3-329
54G;ACT;
Assess
X-ray structure of protein kinase ck2 alpha subunit H148S mutantmonomer3-329
SO4;
Assess
Crystal Structure of CK2alpha with Compound 2 bound to second crystal formmonomer3-329
N5Q;ACT;
Assess
Crystal structure of compound 7 bound to CK2alphamonomer3-329
ATP;ACT;H4N;
Assess
The crystal structure of CK2alpha in complex with compound 14monomer3-329
ACT;AU8;ATP;
Assess
The crystal structure of CK2alpha in complex with compound 31monomer3-329
B4Q;ACT;
Assess
The crystal structure of CK2alpha in complex with compound 11monomer3-329
ACT;DMS;J27;ATP;
Assess
Crystal Structure of CK2alpha with Compound 10 boundmonomer3-329
ACT;54S;
Assess
The crystal structure of CK2alpha in complex with an analogue of compound 1monomer3-329
ACT;ATP;AFK;
Assess
Compound 9 Bound to CK2alphamonomer3-329
ATP;ACT;KEX;
Assess
The crystal structure of CK2alpha in complex with compound 27monomer3-329
ACT;AOK;
Assess
Structure of protein kinase CK2 catalytic subunit with the CK2beta-competitive bisubstrate inhibito…monomer3-329
NA;A0Z;
Assess
Crystal structure of human protein kinase CK2 alpha subunit in complex with the inhibitor CX-4945monomer3-329
3NG;SO4;
Assess
The Structure of CK2alpha with CCh507 boundmonomer3-329
E8K;ATP;
Assess
Structure of Belumosudil bound to CK2alphamonomer3-329
ACT;ICQ;PO4;
Assess
Crystal Structure of CK2alpha with Compound 5 boundmonomer3-329
54Z;ATP;ACT;
Assess
The crystal structure of CK2alpha in complex with analogues of compound 1monomer3-329
ACT;AFW;
Assess
Crystal Structure of CK2alpha with Compound 1 boundmonomer3-329
ACT;P5W;
Assess
Structure of Compound 14 bound to CK2alphamonomer3-329
LVL;ATP;ACT;
Assess
X-ray structure of protein kinase ck2 alpha subunit H148N mutantmonomer3-329
SO4;
Assess
Crystal Structure of CK2alpha with 3,4-dichlorophenethylamine boundmonomer3-329
42J;ACT;
Assess
X-ray structure of protein kinase ck2 alpha subunit H148A mutantmonomer3-329
SO4;
Assess
Crystal structure of human protein kinase CK2 alpha subunit in complex with the inhibitor CX-5279monomer3-329
FU9;SO4;PEG;EDO;
Assess
Crystal structure of CK2a1 with 5-iodotubercidinmonomer2-328
5ID;EDO;
Assess
Crystal Structure of CK2alpha with GTP boundmonomer3-329
GDP;
Assess
Crystal structure of human CK2 alpha in complex with Quinalizarin at pH 8.5monomer3-329
TXQ;SO4;
Assess
Crystal Structure of CK2alphamonomer2-328
ADP;IHP;MG;ACT;
Assess
Compound 20 Bound to CK2alphamonomer3-329
ATP;ACT;KF6;
Assess
Crystal Structure of CK2alpha with Compound 3 boundmonomer2-328
ACT;K82;PO4;
Assess
The crystal structure of CK2alpha in complex with an analogue of compound 22monomer3-329
AU2;
Assess
Crystal structure of human protein kinase CK2 in complex with the inhibitor CX-5011monomer3-329
E1B;SO4;
Assess
The crystal structure of CK2alpha in complex with an analogue of compound 1monomer3-329
ATP;ACT;A9W;
Assess
The crystal structure of CK2alpha in complex with compound 19monomer2-328
ACT;AJK;PO4;
Assess
The crystal structure of CK2alpha in complex with compound 32monomer3-329
B5E;ACT;
Assess
Crystal Structure of CK2alpha with CAM187 boundmonomer3-329
ACT;EZN;
Assess
The crystal structure of CK2alpha in complex with compound 23monomer3-329
ACT;AHK;
Assess
Casein kinase 2 (CK2) bound to inhibitormonomer2-328
CL;0XG;
Assess
Crystal Structure of CK2alpha with N-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methan…monomer2-328
PO4;YRA;
Assess
Crystal structure of CK2alpha with 2-hydroxy-5-methylbenzoic acid and N-(3-(3-chloro-4-(phenyl)benz…monomer2-328
54R;54G;ACT;
Assess
Casein kinase 2 in complex with AZ-Inhibitormonomer2-328
LNH;CL;
Assess
Crystal structure of human CK2 alpha complexed with apigeninmonomer2-328
AGI;EDO;
Assess
Joint X-ray/neutron structure of protein kinase ck2 alpha subunitmonomer3-329
SO4;
Assess
Crystal Structure of CK2alpha with a novel closed conformation of the aD loopmonomer4-329
ACT;
Assess
Crystal structure of CK2alpha with ZT0583 bound.monomer3-328
YTX;ACT;
Assess
Crystal Structure of CK2alpha with 2 molecules of ADP boundmonomer2-327
ADP;ACT;MG;PO4;
Assess
Crystal Structure of CK2alpha with Compound 2 boundmonomer2-327
N5Q;
Assess
Crystal structure of compound 2 bound to CK2alphamonomer2-327
1NP;
Assess
Crystal Structure of CK2alpha with ZT0432 boundmonomer2-327
BR9;ACT;
Assess
The crystal structure of CK2alpha in complex with compound 18monomer2-327
ACT;PO4;B5W;
Assess
Crystal Structure of CK2alpha with Compound 7 boundmonomer3-328
JMB;ACT;
Assess
Crystal Structure of CK2alpha with N-((2-chloro-[1,1'-biphenyl]-4-yl)methyl)butane-1,4-diamine boundmonomer3-328
H83;ACT;
Assess
Crystal structure of CK2 with compound 7bmonomer3-328
CL; 18×EDO;5Y4;
Assess
Crystal structure of CK2alpha with 3-(3-chloro-4-(phenyl)benzylamino)propan-1-ol boundmonomer3-328
ACT;54P;
Assess
Crystal Structure of CK2alpha with N-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methan…monomer2-327
ACT;4IH;PO4;
Assess
1-(2-chloro-[1,1'-biphenyl]-4-yl)-N-methylethanaminemonomer3-328
ADP;IHP;J2P;
Assess
Crystal structure of the catalytic subunit of human protein kinase CK2monomer4-329
Assess
Crystal structure of human CK2 in complex with inositol hexakisphosphatemonomer4-329
Assess
The crystal structure of CK2alpha in complex with compound 4monomer3-327
ACT;A8Q;ATP;
Assess
The crystal structure of CK2alpha in complex with compound 3monomer3-327
ACT;A8Q;ATP;
Assess
Crystal Structure of CK2alpha with N-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methan…monomer4-328
ACT;C98;PO4;
Assess
Crystal structure of compound 2 bound to CK2alphamonomer3-327
PO4;
Assess
Crystal Structure of CK2alpha with N-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methan…monomer3-327
ADP;MG;IHP;ACT;OQC;PO4;
Assess
Crystal Structure of CK2alpha with ZT0432 boundmonomer3-327
PO4;ADP;ACT;RKN;MG;
Assess
Crystal structure of Ck2alpha with ZT0633 boundmonomer3-327
HC4;
Assess
Crystal Structure of CK2alpha with Compound 4 boundmonomer4-327
54E;ATP;
Assess
The crystal structure of CK2alpha in complex with compound 2monomer4-327
A4N;
Assess
Crystal Structure of CK2alpha with N-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methan…monomer4-327
Assess
Crystal structure of CK2alpha with N-(3-(3-chloro-4-(phenyl)benzylamino)propyl)acetamide boundmonomer4-327
ACT;54R;
Assess
Crystal Structure of CK2alpha with N-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methan…monomer4-327
ACT;
Assess
Structure of a chimeric construct of human CK2alpha and human CK2alpha' in complex with a non-hydro…monomer2-325
ANP;MG;CL;SO4;GOL;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5oni.1.Amonomer0.892-335
9YE;100.00
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 25oni.1.Amonomer0.881-199
100.00
Assess